Hackensack, N.J.-based Royal Biologics has received the FDA’s 510(k) clearance for its Maxx-BMC bone marrow aspirate concentration system.

The device is designed to provide an optimal sample of concentrated bone marrow aspirate from a patient at the point of care.

The Maxx-BMC includes the company’s patented "lead screw" technology that allows users to develop a customized point of care for use in orthopedic and sports medicine surgical procedures.

Bone marrow concentrate is used in orthopedics to help promote mature bone growth.

Royal Biologics specializes in advanced cellular technologies and “enhanced autologous healing.”